Elan
Sunday, 01 January 2006
Legal advisers to Elan in the licensing of NanoCrystal® Technology to EntreMed Inc. for Panzem® cancer drug.
RELATED SERVICES
RELATED PEOPLE
RELATED LINKS
Practice Areas
- Administrative Law
- Banking and Finance
- Capital Markets - Equity Capital
- Child Care Law
- Commercial Contracts
- Construction
- Consumer Law
- Corporate
- Corporate Crime, Cyber-crime and White Collar Litigation/Investigations
- Corporate Governance and Compliance
- Corporate Immigration
- Corporate Secretarial
- Crisis Management
- Data Protection/GDPR
- Employment Law
- Energy and Natural Resources
- Environment and Planning
- EU, Competition & Regulated Markets
- Financial Services
- Financial Services Regulatory Investigations
- Freedom of Information
- Health and Safety
- Health and Social Care
- Housing
- Infrastructure, Construction and Energy
- Intellectual Property
- International / FDI
- International and EU Trade
- Licensing
- Life Sciences
- Litigation and Dispute Resolution
- Merger Control
- Mergers & Acquisitions (M&A)
- Outsourcing
- Pensions Law
- Procurement
- Projects and Infrastructure
- Property/Real Estate
- Reputation Management
- Restructuring & Insolvency
- Structured Finance Transactions
- Tax
- Venture Capital and Private Equity
